| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.13T | 2.87T | 2.81T | 2.66T | 2.51T | 2.29T |
| Gross Profit | 1.14T | 1.20T | 1.17T | 1.04T | 940.79B | 812.44B |
| EBITDA | 1.21T | 944.66B | 916.36B | 813.04B | 743.78B | 655.33B |
| Net Income | 469.53B | 351.63B | 346.13B | 290.34B | 317.38B | 192.38B |
Balance Sheet | ||||||
| Total Assets | 18.13T | 16.87T | 16.32T | 15.29T | 14.27T | 13.56T |
| Cash, Cash Equivalents and Short-Term Investments | 1.42T | 1.23T | 1.05T | 1.26T | 971.10B | 959.91B |
| Total Debt | 6.71T | 6.54T | 6.46T | 6.01T | 5.16T | 5.04T |
| Total Liabilities | 13.40T | 12.69T | 12.30T | 11.67T | 10.90T | 10.46T |
| Stockholders Equity | 4.58T | 4.09T | 3.94T | 3.54T | 3.26T | 3.03T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.20T | 1.17T | 777.66B | 990.65B | 1.04T |
| Operating Cash Flow | 0.00 | 1.27T | 1.25T | 881.23B | 1.03T | 1.08T |
| Investing Cash Flow | 0.00 | -1.31T | -1.36T | -1.14T | -784.99B | -1.18T |
| Financing Cash Flow | 0.00 | 146.27B | -100.99B | 480.70B | -330.47B | 20.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥397.28B | 8.49 | ― | 3.65% | 21.22% | -2.77% | |
72 Outperform | ¥4.94T | 10.66 | 10.32% | 3.30% | 6.21% | 11.62% | |
72 Outperform | ¥2.05T | 10.19 | 8.92% | 3.20% | 3.42% | 22.06% | |
70 Outperform | ¥185.26B | 11.64 | ― | 3.30% | 7.36% | -3.80% | |
69 Neutral | ¥746.49B | 10.93 | 7.97% | 3.48% | 6.65% | -4.35% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥341.34B | 14.65 | 3.46% | 3.04% | 10.31% | -40.64% |
ORIX Corporation has announced a series of management and organizational changes effective March 1, 2026, as it refines its corporate structure across business and control units. Executive Officer Reiko Okubo will narrow her remit to focus on the CEO’s Office within the Corporate Strategy and Management Unit, reflecting a clearer separation of responsibilities for new business activities.
In Japan and the Asia-Pacific business, ORIX will set up new Pension Business Promotion and Healthcare & Public Solution departments under its Corporate Business Headquarters, while also creating a new Johoku Area and Johoku Branch Office to sharpen regional coverage. The Corporate Strategy and Management Unit will abolish its New Business Development Department and split Investor Relations and Sustainability into two standalone departments, and the Risk Management Unit will rename its Credit and Investment Information Management Department to Risk Information Management Department, moves that collectively aim to streamline oversight, clarify accountability, and align the organization with evolving client, investor, and regulatory demands.
The most recent analyst rating on (JP:8591) stock is a Buy with a Yen5999.00 price target. To see the full list of analyst forecasts on ORIX stock, see the JP:8591 Stock Forecast page.